Restart Life Sciences Corp.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a NMLSF research report →
Price Chart
About the company
Operating internationally through its various subsidiaries, Restart Life Sciences Corp. functions as a biotechnology firm. Its core endeavors include the creation of natural therapeutic remedies tailored for individuals with autism spectrum disorder, the development of health-promoting foods designed for comprehensive mind and body wellness, and the execution of a psilocybin clinical trial aimed at fragile X syndrome.
- CEO
- Steve Loutskou
- IPO
- 2011
- HQ
- Vancouver, BC, CA
Get TickerSpark's AI analysis on NMLSF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $3.78M
- P/E
- -1.59
- PEG
- 0.19
- P/S
- 8.72
- P/B
- 2.98
- EV/EBITDA
- -2.23
- Div Yield
- 0.00%
- Gross Margin
- -175.04%
- Op Margin
- -365.86%
- Net Margin
- -367.41%
- ROE
- -170.82%
- ROIC
- -101.84%
Latest fiscal year · YoY change
- Revenue
- $0+0.0%
- Gross Profit
- $-1,347+16.1%
- Op Income
- $-1,345,316
- Net Income
- $-1,390,538-718.7%
- EPS
- $-0.00-102.7%
- OCF Growth
- -899.3%
- FCF Growth
- -899.3%
- 52W High
- $0.12
- 52W Low
- $0.01
- 50D MA
- $0.04
- 200D MA
- $0.06
- Beta
- -0.80
- RSI (14)
- 67
- Avg Volume
- 577
No earnings-call transcripts are available for NMLSF yet.
- Free Float
- 84.5%
- Shares Outstanding
- 62.51M
- Float Shares
- 52.84M
of shares held by institutions
1 13F filers
Our NMLSF coverage
Recent articles, reports, and earnings notes.
No research on NMLSF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate NMLSF report →Restart Life Advances BrainQ SuperFood Towards 2027 Production
newsfilecorp.com · Nov 19
Restart Life Advances BrainBalls Toward Planned 2027 Canadian Launch and U.S. Expansion
newsfilecorp.com · Nov 17
Restart Life Advances Youth+love Collagen Toward Planned 2027 Launch
newsfilecorp.com · Nov 12
Restart Life Launches CPG Co-Packing Services for Select Brand Partners
newsfilecorp.com · Nov 11
Restart Life Advances Licensed Intellectual Property Portfolio Toward Commercial Launch
newsfilecorp.com · Oct 7
Restart Life Sciences Launches HC Protein+ Products Online and Advances AI-Driven E-Commerce Strategy
newsfilecorp.com · Sep 23
Holy Crap Foods to Exhibit at CHFA NOW Toronto, Debuting New Protein SKUs and Interactive AI Photo Experience
newsfilecorp.com · Sep 15
Restart Life Sciences Reports Second Quarter 2026 Results Highlighted by 146% Sequential Revenue Growth
newsfilecorp.com · Sep 3
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.